Home › Funds › Washington Trust Advisors, Inc. › EW
Washington Trust Advisors, Inc. position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Washington Trust Advisors, Inc. reported holding 129,034 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 0.80% of its reported portfolio and ranking #30 among its reported holdings. Washington Trust Advisors, Inc. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Washington Trust Advisors, Inc.'s EW position evolved
Washington Trust Advisors, Inc. first disclosed a stake in EW in Q3 2023 at 72,800 shares (US$5.0M). The position peaked in Q4 2025 at 138,005 shares, worth US$11.8M. Across 13 filings, Washington Trust Advisors, Inc. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 129,034 shares valued at US$11.1M. Notable position changes include a 33% increase in Q4 2023 (shares rose 25% over the following quarter), a 25% increase in Q3 2024 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 72.80K | $5.04M | New |
| Q4 2023 | 96.94K | $7.39M | Add |
| Q1 2024 | 94.77K | $9.06M | Reduce |
| Q2 2024 | 92.17K | $8.51M | Reduce |
| Q3 2024 | 115.66K | $7.63M | Add |
| Q4 2024 | 113.41K | $8.40M | Reduce |
| Q1 2025 | 112.89K | $8.18M | Hold |
| Q2 2025 | 112.96K | $8.83M | Hold |
| Q3 2025 | 130.59K | $10.16M | Add |
| Q4 2025 | 138.00K | $11.76M | Add |
| Q1 2026 | 133.81K | $10.72M | Reduce |
| Q2 2026 | 129.61K | $11.72M | Reduce |
| Q3 2026 | 129.03K | $11.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on Washington Trust Advisors, Inc.
FAQ
How long has Washington Trust Advisors, Inc. held EW?
Washington Trust Advisors, Inc. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Washington Trust Advisors, Inc.'s current position in EW?
As of Q3 2026, Washington Trust Advisors, Inc. holds 129.03K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $11.14M, representing 0.80% of its reported portfolio and ranking #30.
Has Washington Trust Advisors, Inc. been buying or selling EW?
In the latest 13F filing (Q3 2026), Washington Trust Advisors, Inc. held unchanged its position in EW. The position peaked in Q4 2025 at 138.00K shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.